De Novo Antibody Sequencing Case Study
Abterra Bio uses bioinformatics and mass spectrometry to reconstructs the full amino acid sequence of both antibody chains. We’ve successfully sequenced human, mouse, rat, hamster, rabbit, and llama antibodies. This approach can be applied across any species and isotype, including IgG’s and IgM’s.
Contact us to learn more about how our Valens™ de novo antibody sequencing can recover the full antibody sequence when no source cell is available!
Tell Us About Your Project
Related Resources
For 100% sequence accuracy, antibody sequencing experience matters. Read our blog post to understand more about our service and why you would need de novo sequencing.
New Service: Alicanto for Antibody Discovery from Human Serum
We released Alicanto for Antibody Discovery from Human Serum at PEGS Boston! Click to watch our CEO, Dr. Natalie Castellana’s talk!
Case Study: Reptor Phage Enrichment
This case study aimed to identify Cas9-binding single domain antibodies using phage display and Reptor immune repertoire sequencing.
Abterra Bio Has Moved To Sorrento Valley
Abterra Bio Has Moved To Sorrento Valley In 2009, Abterra Bio began as Digital Proteomics LLC, a spin-out of the University of California – San Diego. Founders Pavel Pevzner and Vineet Bafna, as well as Natalie Castellana, Stefano Bonissone, and Anand Patel have been...